Patients who have already attempted two licensed medications to treat their condition may have the opportunity to join the biggest medicinal cannabis registry, Project Twenty21.
Project Twenty21 aims to create the largest body of evidence for the efficacy of medicinal cannabis. The initiative will use collated data to support policy makers as they review medicinal cannabis availability, and affordability for patients who would benefit from its use. The project will assist prescribers operating in private practice and advance the potential for UK Government Health (NHS) funding. Project Twenty21 will focus on these conditions:
- Anxiety Disorder
- Chronic Pain
- Multiple Sclerosis (MS)
- Post-Traumatic Stress Disorder (PTSD)
- Substance Use Disorder (as a harm reduction strategy)
- Tourette’s Syndrome